Connor, Clark & Lunn Investment Management (CC&L)’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-129,093
| Closed | -$12.8M | – | 1170 |
|
|
2019
Q3 | $12.8M | Sell |
129,093
-550
| -0.4% | -$52.3K | 0.09% | 156 |
|
|
2019
Q2 | $12M | Buy |
129,643
+18,175
| +16% | +$1.73M | 0.08% | 174 |
|
|
2019
Q1 | $10.5M | Buy |
111,468
+74,500
| +202% | +$6.52M | 0.07% | 184 |
|
|
2018
Q4 | $2.37M | Buy |
36,968
+4,850
| +15% | +$358K | 0.02% | 386 |
|
|
2018
Q3 | $2.87M | Sell |
32,118
-235,500
| -88% | -$20.8M | 0.02% | 384 |
|
|
2018
Q2 | $21.3M | Sell |
267,618
-171,983
| -39% | -$14.3M | 0.12% | 131 |
|
|
2018
Q1 | $39.2M | Buy |
439,601
+107,608
| +32% | +$10.3M | 0.24% | 82 |
|
|
2017
Q4 | $34.6M | Buy |
331,993
+174,800
| +111% | +$19.7M | 0.2% | 90 |
|
|
2017
Q3 | $22.9M | Buy |
157,193
+105,750
| +206% | +$14.4M | 0.14% | 119 |
|
|
2017
Q2 | $6.68M | Buy |
51,443
+17,025
| +49% | +$2.09M | 0.04% | 236 |
|
|
2017
Q1 | $4.28M | Sell |
34,418
-1,200
| -3% | -$144K | 0.03% | 274 |
|
|
2016
Q4 | $4.12M | Buy |
35,618
+4,300
| +14% | +$479K | 0.03% | 274 |
|
|
2016
Q3 | $3.27M | Buy |
31,318
+118
| +0.4% | +$12.8K | 0.02% | 299 |
|
|
2016
Q2 | $3.08M | Sell |
31,200
-10,625
| -25% | -$1.1M | 0.02% | 300 |
|
|
2016
Q1 | $4.19M | Sell |
41,825
-96,825
| -70% | -$9.97M | 0.03% | 243 |
|
|
2015
Q4 | $16.6M | Sell |
138,650
-15,625
| -10% | -$1.81M | 0.14% | 102 |
|
|
2015
Q3 | $16.7M | Buy |
+154,275
| New | +$19.1M | 0.14% | 95 |
|
|
2014
Q3 | – | Sell |
-16,800
| Closed | -$1.54M | – | 629 |
|
|
2014
Q2 | $1.54M | Buy |
+16,800
| New | +$1.28M | 0.01% | 274 |
|
|
2014
Q1 | – | Sell |
-126,368
| Closed | -$11.3M | – | 851 |
|
|
2013
Q4 | $11.3M | Buy |
126,368
+105,068
| +493% | +$8.31M | 0.09% | 96 |
|
|
2013
Q3 | $1.69M | Buy |
21,300
+10,100
| +90% | +$708K | 0.02% | 218 |
|
|
2013
Q2 | $691K | Buy |
+11,200
| New | +$674K | 0.01% | 314 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Connor, Clark & Lunn Investment Management (CC&L)'s CELG Position: Q4 2019 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 129,093 shares — an estimated $12.8M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $39.2M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 129,093 Celgene Corp shares in Q4 2019, an estimated $12.8M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Celgene Corp position peaked at $39.2M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2019, filed 12 Feb 2020.